Results
94
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
94 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CALTX | SEK 206.40 | 0.3% | 131.1% | SEK 11.2b | SEK 221.25 | PS8.5x | E52.9% | n/a | Pharmaceuticals & Biotech | ||
KEBNI B | SEK 1.46 | -3.4% | -4.7% | SEK 395.3m | SEK 2.20 | PS4.3x | E90.4% | n/a | Tech | ||
YUBICO | SEK 266.00 | 13.2% | 164.9% | SEK 22.9b | SEK 267.50 | PE138.3x | E43.8% | n/a | Software | ||
CTT | SEK 286.00 | -9.8% | 32.4% | SEK 3.6b | n/a | PE35.2x | E23.4% | 1.9% | Capital Goods | ||
SILEON | SEK 0.50 | 1.2% | -88.6% | SEK 25.1m | n/a | PB1.6x | E109.3% | n/a | Software | ||
YIELD | SEK 2.58 | -1.9% | -63.6% | SEK 147.8m | SEK 9.00 | PB1.7x | E103.4% | n/a | Diversified Financials | ||
EDYOU | SEK 0.41 | -21.2% | -51.1% | SEK 15.3m | n/a | PB0.2x | E63.1% | n/a | Media | ||
BIOA B | SEK 225.60 | -4.4% | -24.1% | SEK 19.9b | SEK 368.00 | PS79x | E50.9% | 0% | Pharmaceuticals & Biotech | ||
BIOVIC B | SEK 2.60 | 8.1% | -58.8% | SEK 218.5m | SEK 7.90 | PS30x | E73.8% | n/a | Pharmaceuticals & Biotech | ||
INCOAX | SEK 2.40 | -1.6% | -24.8% | SEK 259.6m | SEK 3.65 | PS2.7x | E104.9% | n/a | Tech | ||
ORGC | SEK 3.79 | -3.8% | -17.6% | SEK 371.9m | SEK 3.00 | PS2.7x | E109.2% | n/a | Materials | ||
CRAD B | SEK 45.60 | 2.4% | 58.1% | SEK 1.5b | SEK 57.00 | PE28.7x | E33.9% | n/a | Healthcare | ||
FLEXQ | SEK 10.20 | -7.3% | -60.5% | SEK 136.7m | SEK 25.00 | PS1.1x | E111.9% | n/a | Capital Goods | ||
ORT B | SEK 9.46 | -15.5% | 33.6% | SEK 350.8m | SEK 18.00 | PS5.7x | E67.8% | n/a | Healthcare | ||
CTM | SEK 6.26 | 2.8% | -74.3% | SEK 473.6m | SEK 29.70 | PB0.2x | E115.4% | 0% | Media | ||
4C | SEK 19.00 | -11.6% | -32.3% | SEK 657.2m | SEK 24.00 | PS2.2x | E89.6% | n/a | Software | ||
KLAR | SEK 0.32 | -5.9% | -47.0% | SEK 41.3m | SEK 1.00 | PB1.4x | E61.3% | n/a | Pharmaceuticals & Biotech | ||
TRUE B | SEK 35.66 | 1.5% | -20.5% | SEK 12.3b | SEK 54.83 | PE25.8x | E21.4% | 1.1% | Software | ||
MIDS | SEK 1.14 | -12.7% | -54.4% | SEK 239.9m | SEK 2.80 | PS3.7x | E89.9% | n/a | Semiconductors | ||
SENZA | SEK 7.15 | 1.4% | -34.7% | SEK 211.0m | SEK 16.50 | PS4.1x | E67.8% | n/a | Pharmaceuticals & Biotech | ||
EQT | SEK 325.00 | -5.3% | 32.7% | SEK 384.6b | SEK 363.62 | PE109.9x | E57.5% | 1.1% | Diversified Financials | ||
NIUTEC | SEK 6.74 | 0.6% | -43.6% | SEK 136.0m | SEK 9.50 | PB1.6x | E94.1% | n/a | Capital Goods | ||
EGTX | SEK 6.16 | 21.3% | 39.2% | SEK 1.8b | SEK 13.30 | PS28.7x | E98.6% | n/a | Pharmaceuticals & Biotech | ||
ENZY | SEK 2.00 | -16.7% | -28.4% | SEK 346.8m | SEK 4.13 | PS7.7x | E102.7% | n/a | Pharmaceuticals & Biotech |